Our Team

Soricimed’s experienced team is committed to the development of targeted therapies for solid tumor cancers.

Paul Gunn

President & CEO

Bob Cory

Vice President Business Development & COO

Camille Belliveau

Director

Chris Rice

Senior Scientist

Dominique Dugourd

Vice President Research & Development

Helen Macnab-Gunn

Office Administrator

Jack Stewart

Chief Scientific Officer & Director

Ken Keirstead

Director

Michelle Davey

Senior Scientist

Rick Pryde

Director

Sam Magee

Financial Analyst

Tom Reeves

Chairman

Tyler Lutes

Senior Scientist

Interested in our work?

Join the team

Get in Touch

Sign up to receive updates from Soricimed

Powered by Innovasium